Standout Papers

Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabete... 2017 2026 2020 2023 403
  1. Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis (2017)
    M. Angelyn Bethel, Rishi Patel et al. The Lancet Diabetes & Endocrinology

Immediate Impact

68 standout
Sub-graph 1 of 20

Citing Papers

Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
2024 Standout
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
2024 Standout
2 intermediate papers

Works of Peter Merrill being referenced

Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial
2019
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
2017 Standout

Author Peers

Author Last Decade Papers Cites
Peter Merrill 518 241 192 221 16 787
Sarah Nethercott 745 234 173 193 10 983
Alistair Roddick 345 273 216 126 12 729
Sean L. Zheng 310 457 227 137 25 933
Nadia Lascar 511 201 170 144 13 946
Carla Lluís-Ganella 138 288 227 235 26 779
Amarachi Umez-Eronini 662 275 216 263 16 866
James J. Chamberlain 433 154 190 134 15 856
Elena Cerquetani 415 302 111 137 29 922
K. G. Stanton 368 308 154 75 25 952
Louisa Y.F. Wong 327 189 295 115 15 730

All Works

Loading papers...

Rankless by CCL
2026